Agoracom: Small Cap Investment - Mannkind - Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healt

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

brentie98

Rank: President [?]

Points: 5496 [?]

Votes: 21 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healt

posted on Jul 25, 2012 09:27AM

Published: July 25, 2012

Obesity, heart disease and diabetes together constitute a healthcare mega-trend that promises many profitable stock investments for the next 25 years. Our picks in the medium term in this space are Arena Pharmaceuticals (ARNA), Amarin Pharmaceuticals (AMRN), and MannKind Corporation (MNKD).

http://seekingalpha.com/article/746671-obesity-heart-disease-and-diabetes-a-biotech-triumvirate-to-profit-from-healthcare-mega-trends-in-the-medium-term

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply